Listing Page

Category: API Sourcing

Why Biologics Are a Key Driver of Pharmaceutical Sourcing
Over the last several decades, the global pharmaceutical industry has experienced a significant shift...
Read More >
Overcoming API Challenges for Novel Drug Delivery Systems
The 505(b)(2) regulatory pathway is an increasingly popular method of getting drug approval – and one...
Read More >
Reshoring Early-Stage Pharma
The Emergence of a Post COVID-19 Risk Mitigation Strategy Over the last few decades, pharma companies...
Read More >
LGM Helps Pharma Manage Supply Chain Risks with Added Services Through Nexgen Acquisition
COVID-19 has put supply chain risk management practices under the microscope. Coming on the heels of...
Read More >
Can the U.S. Stop Buying Drugs from China?
The SARS-CoV-2 pandemic has drawn significant attention to just how much US pharmaceutical manufacturers...
Read More >
A Look at Reshoring Drug Manufacturing: A Q&A With LGM Pharma’s Hamilton Lenox
When SARS-CoV-2 arrived on American shores this Spring, concerns about overextended drug supply chains...
Read More >